ACH-806, an NS4A Antagonist, Inhibits Hepatitis C Virus Replication by Altering the Composition of Viral Replication Complexes

Treatment of hepatitis C patients with direct-acting antiviral drugs involves the combination of multiple small-molecule inhibitors of distinctive mechanisms of action. ACH-806 (or GS-9132) is a novel, small-molecule inhibitor specific for hepatitis C virus (HCV). It inhibits viral RNA replication i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yang, Wengang, Sun, Yongnian, Hou, Xiaohong, Zhao, Yongsen, Fabrycki, Joanne, Chen, Dawei, Wang, Xiangzhu, Agarwal, Atul, Phadke, Avinash, Deshpande, Milind, Huang, Mingjun
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3697357/
https://ncbi.nlm.nih.gov/pubmed/23629709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02630-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados